Results 141 to 150 of about 30,744 (233)

Anticancer potential of 2,2'-bipyridine hydroxamic acid derivatives in head and neck cancer therapy. [PDF]

J Comput Aided Mol Des
Shetty MG, Dey B, Pai P, Sundara BK, Satyamoorthy K, Oruganti S, Nayak UY, Ashwini T.   +7 more
europepmc   +1 more source

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications. [PDF]

ACS Omega, 2021
Citarella A, Moi D, Pinzi L, Bonanni D, Rastelli G.   +4 more
europepmc   +1 more source

Multi-Walled Carbon Nanotubes Functionalized with Hydroxamic Acid Derivatives for the Removal of Lead from Wastewater: Kinetics, Isotherm, and Thermodynamic Studies. [PDF]

Polymers (Basel), 2022
Al-Faiyz YSS, Gouda M.
europepmc   +1 more source

Pro-fluorescent ethynylthiophene-based <i>o</i>-nitrobenzyl photolabile protecting group for hydroxamic acid synthesis. [PDF]

Org Biomol Chem
Campbell AD, Gorla L, Adjei-Sah O, Williams B, Ajagbe SO, Gozem S, Halim MA, Saint-Louis CJ.   +7 more
europepmc   +1 more source

Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma Cells. [PDF]

Front Genet, 2022
Huang H, Fu Y, Duan Y, Zhang Y, Lu M, Chen Z, Li M, Chen Y.   +7 more
europepmc   +1 more source

Effect of Suberoylanilide Hydroxamic Acid and Phytosulfokine-Alpha on Successful Plant Regeneration from Embryogenic Callus-Derived Protoplasts of Garlic (<i>Allium sativum</i> L.). [PDF]

Int J Mol Sci
Stelmach-Wityk K, Szymonik K, Kadluczka D, Jedrzejczyk I, Grzebelus E.   +4 more
europepmc   +1 more source

Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge. [PDF]

ACS Pharmacol Transl Sci, 2022
Truong N, Goodis CC, Cottingham AL, Shaw JR, Fletcher S, Pearson RM.   +5 more
europepmc   +1 more source

Targeting neuroblastoma with hydroxamic acid based HDAC1 and HDAC2 inhibitors: Insights from in vitro and in vivo studies. [PDF]

Invest New Drugs
Pai P, Reddy Y, Das I, Venkidesh BS, Bhandari P, Rao P, Oruganti S, Prasad K, Shetty MG, Satyamoorthy K, Sundara BK.   +10 more
europepmc   +1 more source

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma. [PDF]

Front Oncol, 2021
Wang H, Shi L, Wang Z.
europepmc   +1 more source

Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo. [PDF]

Front Pharmacol
Chatterjee E, Sharma R, Dey B, Singh H, Naik A, Khan A, Basak S, Bansode A, Sachdeva R, Sharma A, Kumar R, Naik P, Singh PK, Nepali K, Guru SK.   +14 more
europepmc   +1 more source